Serena Quattrucci

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Eitan Kerem, Michael W. Konstan, K. De Boeck et al. · The Lancet Respiratory Medicine · 2014 · 333 citations · Full text

Allergy, Placebo-controlled Phase 3, Clinical Trials +3

Dysfunctional CFTR Alters the Bactericidal Activity of Human Macrophages against Pseudomonas aeruginosa

Paola Del Porto, Noemi Cifani, Simone Guarnieri et al. · PLoS ONE · 2011 · 163 citations · Full text

Pathogenic Microbiology, Inflammatory Lung Disease, Lung Inflammation +20

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates

Valerio Iebba, Valentina Totino, Floriana Santangelo et al. · Frontiers in Microbiology · 2014 · 106 citations · Full text

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients

Serena Schippa, Valerio Iebba, Floriana Santangelo et al. · PLoS ONE · 2013 · 98 citations · Full text

Synergistic Post-Transcriptional Regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 Specific Binding

Francesca Megiorni, Samantha Cialfi, Carlo Dominici et al. · PLoS ONE · 2011 · 88 citations · Full text